High Throughput IPSC Production
iXCells provides integrated iPSC and human cell engineering services that enable predictive, scalable, and translationally relevant research. From donor tissue to assay-ready cells, our platform combines iPSC generation, CRISPR genome editing, differentiation, and primary cell isolation within one scientifically rigorous workflow.
High-Throughput iPSC Production,
Built as an Extension of Your Lab
iXCells partners with large pharma and biotech teams as a seamless extension of their internal laboratories, delivering high-throughput iPSC generation at the scale modern discovery demands. We empower you to leverage your own or IXCells sourced starting material. From hundreds to thousands of patient-derived iPSC lines, we provide the speed, consistency, and scientific rigor required to power long-term, data-driven discovery programs.
Talk with our team about scaling your iPSC workflows
- Hundreds to thousands of patient-derived iPSC lines delivered per program
- Parallel production across dozens to hundreds of donors at a time
- Throughput in excess of 200 lines per month, high success rate maintained at > 95%, custom characterization
Industrial Scale Without Compromising Science
Our high-throughput iPSC platform is designed for programs where volume, quality, and reproducibility must coexist. We support parallel reprogramming, expansion, and standardized characterization to ensure reliable biological inputs across large datasets and extended timelines working side by side with your team. Whether you need to rapidly expand capacity or sustain production across multiple years, iXCells integrates seamlessly into your existing discovery ecosystem.
You bring the questions. We deliver the cellular foundation to help answer them.
Designed for Large Economy of Scale, Complex Disease Programs
Designed for large, complex disease programs, iXCells enables scalable access to patient-derived iPSC models for indications such as neurodegenerative disease and oncology, where biological diversity and statistical power are critical By delivering consistent, validated cell models at high volume, we support investigation of disease mechanisms, evaluation of therapeutic hypotheses, and high-throughput screening at meaningful scale.
Our standardized yet flexible workflows create a true economy of scale, reducing per-line costs, accelerating timelines, and improving dataset consistency as programs grow, allowing teams to generate robust biology without the burden of building or maintaining equivalent internal infrastructure.
Our high-throughput model creates a true economy of scale for drug discovery teams. By standardizing core workflows while remaining flexible at the program level, we reduce per-line costs as volume increases, shorten cycle times, and improve consistency across large datasets. This approach enables teams to move beyond small pilot studies and generate the scale of biology needed for confident decisions, without building or maintaining equivalent internal infrastructure.
A Partner for Long-Running Discovery Efforts
iXCells is built to support over multiple year collaborations, not one time projects. Our workflows are engineered for repeatability, comparability, and sustained output, allowing teams to scale capacity without rebuilding internal infrastructure.
We integrate closely with your scientific teams to align on quality expectations, timelines, and program goals so your discovery engine keeps moving without interruption.
Make Scale a Strategic Advantage
When high-throughput biology is foundational to your discovery strategy, execution matters.